1-2 of 2
Manuela Stulle
Close
Sort by
Journal Articles

BCR-ABL1 Levels at First Month after TKI Discontinuation Predict Subsequent Maintenance of Treatment-Free Remission: A Study from the "Gruppo Triveneto LMC"

Sara Di Giusto, PhD, Eleonora Toffoletti, MD, Massimiliano Bonifacio, MD, Gianni Binotto, MD, Maria Cristina Miggiano, MD, Elisabetta Calistri, MD, Manuela Stulle, MD, Anna Ermacora, MD, Rossella Stella, MD, Luigi Scaffidi, MD, Fabio D'Amore, MD, Giorgia Scotton, MD, Giovanna De Matteis, PhD, Roberta Bertorelle, PhD, Renato Fanin, MD, Mauro Krampera, MD PhD, Gianpietro Semenzato, MD, Daniela Damiani, MD, Mario Tiribelli, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-135968
Published: 2020
Journal Articles

Next Generation Sequencing-Based BCR-ABL1 Kinase Domain Mutation Screening in De Novo and Tyrosine Kinase Inhibitor-Resistant Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of a Prospective Study

Simona Soverini, PhD, Luana Bavaro, Margherita Martelli, Caterina De Benedittis, PhD, Cristina Papayannidis, Antonio Percesepe, MD PhD, Maria Antonella Laginestra, PhD, Simona Sica, MD, Federica Sorà, MD, Francesco Albano, MD, Livio Pagano, Marianna Criscuolo, Sara Galimberti, Marzia Salvucci, MD, Mario Annunziata, Giovanni Marconi, Antonio Curti, Sabina Russo, Annalisa Imovilli, Daniele Mannina, MD, Dario Ferrero, MD, Manuela Stulle, Claudia Basilico, MD, Elisabetta Abruzzese, Flavio Mignone, Stefano A. Pileri, MD PhD, Giovanni Martinelli, Michele Cavo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4078.
https://doi.org/10.1182/blood-2018-99-117028
Published: 2018